A telephone replay will be available approximately one hour following completion of the call through May 27, 2024. To access the replay, please dial 844-512-2921 (in the U.S.) or 412-317-6671 (outside ...
The Schwab Trading Activity Index™ (STAX) decreased to 48.87 in April, down from its score of 51.65 in March. The only index ...
GAAP earnings per share (“EPS”) of $0.04 Adjusted EPS of $0.08 Revenue grew 21% year-over-year and 4% quarter-over-quarter to $634 million US commercial highlights US commercial ...
or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit ...
“The first quarter of 2024 signifies a robust commencement and the dawn of a new era for GlobalX,” said Chris Jamroz, Executive Chairman of GlobalX. “Since our inception in 2019, ...
UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, ...
4m
Everi Holdings Inc. ("Everi" or the "Company"), announced that it has terminated its stock repurchase program effective May 2, 2024. On May 3, 2023, the Company's Board of Directors approved the stock ...
SAN DIEGO, May 06, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its first quarter 2024 financial results and provided a corporate update.
Management will discuss first quarter 2024 results on a webcast at 2:00 p.m. PT (5:00 p.m. ET), today, Monday, May 6, 2024. The webcast can be accessed on the Investor Relations section of the ...
Common stock, $0.001 par value; 100,000 shares authorized; 30,371 and 30,036 shares issued and outstanding, respectively, at March 31, 2024; and 30,297 and 29,948 shares issued and outstanding, ...
United States Lime & Minerals, Inc. (NASDAQ: USLM) (the “Company”) today announced that it will conduct a split of its outstanding shares of common stock at a ratio of 5:1, ...
A detailed schedule for the 2024 guidance range as well as additional assumptions is included in this press release. Results for the three months ended March 31, 2024 compared to the same period in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback